Menu

Yaëlle PIBOULEU

Boulogne-Billancourt

En résumé

 Proven strategic experience: Latin America & Asia Pacific portfolio management for on market and both early and late stage products; Asia Pacific governance review committee member; multiple examples of leading highly complex projects to aid strategic decision-making (companion diagnostic partnering opportunity, in-licensing opportunity, company acquisition, China & India portfolio prioritization and valuation, China development projects valuation in various therapeutic area).
 Extensive knowledge of emerging markets: Latin America in-market experience (Panama) with close collaboration with 23 affiliates; in-market experience in China gained through working with the Asia Pacific Commercial & Product development organizations and the China affiliate.
 Recognized leadership skills: operates with passion, positivity and integrity; led cross-functional teams of 5 to 10 individuals to deliver results; manages the Asia Pacific governance review committee operations and decision-making.

Core competencies include: Portfolio planning & analysis • Portfolio reporting • Project management • Project valuation • Governance committee management • Communication skills • Multilingual (Fluent in French, English and Spanish) and multicultural awareness

Mes compétences :
Business Case
Business development
Communication
English
Forecasting
Management transversal
Market analysis
Planning
Spanish
Strategic planning
Gestion de portefeuille projets

Entreprises

  • Roche - Senior Associate Asia Pacific (APAC) New Product Planning, Shanghai (China)

    Boulogne-Billancourt 2012 - maintenant APAC governance review committee Business Manager and project manager for key initiatives and projects sponsored by the APAC Region.
     Accelerated integration of China in the global phase 3 design discussions by orchestrating the China portfolio prioritization process and leading cross functional teams to prioritize the China interest in 25 early stage compounds.
     Enhanced China programs valuation for phase 3 funding requests to corporate management by developing a specific China program valuation methodology.
     Clarified the path for the assessment and approval of APAC partnering opportunities by customizing the APAC partnering working model.
     Led the assessment of the future India portfolio. Mobilized and coached the India Marketing & Medical teams to provide recommendations on future investments to make to support Roche product launches in India in the next 5 to 10 years.
     Spearheaded the 2013 Product Development in Asia Pacific annual meeting organization, managing a budget of 0.5MCHF and over 300 participants. Managed a cross-functional team to deliver the meeting on time, within budget and +80% attendee satisfaction.
     People management: Recruited and supervised a China portfolio analyst on a 6-months development opportunity and acts as a mentor for 2 mentees.

  • Roche - Asia-Pacific Portfolio Manager, Shanghai (China)

    Boulogne-Billancourt 2011 - 2012 Defined and delivered portfolio reports, produced strategic portfolio analytics and insights to recommend management action. Applied project and process management expertise to committee and initiative management.
     Built portfolio analysis & reporting process that supports communication of accurate and transparent China portfolio information within the organization and regional management needs.
     Pioneered a resource management gap analysis supporting executive management with resource planning and helping to ensure decisions were aligned with portfolio priorities.
     Launched the Time Recording program in China. Trained and mobilized the organization resulting in +95% compliance exceeding the corporate goal.
     Managed 2 cross-functional teams of ~ 10 individuals, planning and delivering on 2 NDA fillings and 1 CTA filing for China.

  • Sanofi-Aventis - Latin America Portfolio and Business Development Manager, Panama City (Panama)

    Paris 2009 - 2010 Analyzed opportunities for life cycle management of existing prescription brands, branded generics and OTC, as well as new brand and franchise extension for LATAM. Project managed the evaluation of opportunities (market analysis, NPV) and related feasibility assessments. Ensured implementation of decisions at zone and country level.
     Designed standardized templates to harmonize and consolidate affiliates input. Educated affiliates on management expectations to support decision making.
     Coordinated the assessment of 20+ projects in 5 therapeutic areas across 23 affiliates with daily interaction with executive management, leading to the identification and implementation of new commercial opportunities e.g. Somatuline®, Ipsen in-licensing opportunity (generated 2M€ in 2 months) and acquisition of Chattem in 2010 ($1.9 billion deal).

  • HYBRIGENICS - Project Leader Marketing, Paris

    2008 - 2008 Defined the communication plan and marketing direct activity.
     Increased the customer transformation rate by leading the identification and implementation of a tailored direct marketing solution.

  • BioMérieux - Business Developer, Lyon

    MARCY-L'ETOILE 2007 - 2007 Analyzed pharmaceutical landscape and identified opportunities for the development of the Theragnostics franchise.
     Identified partnering opportunities for the development of companion diagnostics tests, provided business model analysis and recommendations that led to partnering discussions with Merck, GSK & Ipsen.

Formations

Réseau

Annuaire des membres :